Trial record 1 of 1 for:    hvtn 505 | hiv | vaccine | niaid
Previous Study | Return to List | Next Study

Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
HIV Vaccine Trials Network
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00865566
First received: March 17, 2009
Last updated: August 12, 2014
Last verified: August 2014